162 related articles for article (PubMed ID: 20842449)
1. Down-regulation of achaete-scute complex homolog 1 (ASCL1) in neuroblastoma cells induces up-regulation of insulin-like growth factor 2 (IGF2).
Li J; Neumann I; Volkmer I; Staege MS
Mol Biol Rep; 2011 Mar; 38(3):1515-21. PubMed ID: 20842449
[TBL] [Abstract][Full Text] [Related]
2. Shutdown of achaete-scute homolog-1 expression by heterogeneous nuclear ribonucleoprotein (hnRNP)-A2/B1 in hypoxia.
Kasim M; Benko E; Winkelmann A; Mrowka R; Staudacher JJ; Persson PB; Scholz H; Meier JC; Fähling M
J Biol Chem; 2014 Sep; 289(39):26973-26988. PubMed ID: 25124043
[TBL] [Abstract][Full Text] [Related]
3. Identification of Achaete-scute complex-like 1 (ASCL1) target genes and evaluation of DKK1 and TPH1 expression in pancreatic endocrine tumours.
Johansson TA; Westin G; Skogseid B
BMC Cancer; 2009 Sep; 9():321. PubMed ID: 19744316
[TBL] [Abstract][Full Text] [Related]
4. HIF2A and IGF2 expression correlates in human neuroblastoma cells and normal immature sympathetic neuroblasts.
Mohlin S; Hamidian A; Påhlman S
Neoplasia; 2013 Mar; 15(3):328-34. PubMed ID: 23479510
[TBL] [Abstract][Full Text] [Related]
5. Intelectin 1 suppresses the growth, invasion and metastasis of neuroblastoma cells through up-regulation of N-myc downstream regulated gene 2.
Li D; Mei H; Pu J; Xiang X; Zhao X; Qu H; Huang K; Zheng L; Tong Q
Mol Cancer; 2015 Feb; 14():47. PubMed ID: 25889839
[TBL] [Abstract][Full Text] [Related]
6. ASCL1 Reorganizes Chromatin to Direct Neuronal Fate and Suppress Tumorigenicity of Glioblastoma Stem Cells.
Park NI; Guilhamon P; Desai K; McAdam RF; Langille E; O'Connor M; Lan X; Whetstone H; Coutinho FJ; Vanner RJ; Ling E; Prinos P; Lee L; Selvadurai H; Atwal G; Kushida M; Clarke ID; Voisin V; Cusimano MD; Bernstein M; Das S; Bader G; Arrowsmith CH; Angers S; Huang X; Lupien M; Dirks PB
Cell Stem Cell; 2017 Aug; 21(2):209-224.e7. PubMed ID: 28712938
[TBL] [Abstract][Full Text] [Related]
7. EGFR mediates activation of RET in lung adenocarcinoma with neuroendocrine differentiation characterized by ASCL1 expression.
Bhinge K; Yang L; Terra S; Nasir A; Muppa P; Aubry MC; Yi J; Janaki N; Kovtun IV; Murphy SJ; Halling G; Rahi H; Mansfield A; de Andrade M; Yang P; Vasmatzis G; Peikert T; Kosari F
Oncotarget; 2017 Apr; 8(16):27155-27165. PubMed ID: 28460442
[TBL] [Abstract][Full Text] [Related]
8. PCP4/PEP19 downregulates neurite outgrowth via transcriptional regulation of Ascl1 and NeuroD1 expression in human neuroblastoma M17 cells.
Kitazono I; Hamada T; Yoshimura T; Kirishima M; Yokoyama S; Akahane T; Tanimoto A
Lab Invest; 2020 Dec; 100(12):1551-1563. PubMed ID: 32641824
[TBL] [Abstract][Full Text] [Related]
9. Basic helix-loop-helix transcription factor profiling of lung tumors shows aberrant expression of the proneural gene atonal homolog 1 (ATOH1, HATH1, MATH1) in neuroendocrine tumors.
Westerman BA; Breuer RH; Poutsma A; Chhatta A; Noorduyn LA; Koolen MG; Postmus PE; Blankenstein MA; Oudejans CB
Int J Biol Markers; 2007; 22(2):114-23. PubMed ID: 17549667
[TBL] [Abstract][Full Text] [Related]
10. Chrysin suppresses achaete-scute complex-like 1 and alters the neuroendocrine phenotype of carcinoids.
Somnay YR; Dull BZ; Eide J; Jaskula-Sztul R; Chen H
Cancer Gene Ther; 2015 Oct; 22(10):496-505. PubMed ID: 26403073
[TBL] [Abstract][Full Text] [Related]
11. Achaete-scute complex homologue 1 regulates tumor-initiating capacity in human small cell lung cancer.
Jiang T; Collins BJ; Jin N; Watkins DN; Brock MV; Matsui W; Nelkin BD; Ball DW
Cancer Res; 2009 Feb; 69(3):845-54. PubMed ID: 19176379
[TBL] [Abstract][Full Text] [Related]
12. The human Achaete-Scute homologue 2 (ASCL2,HASH2) maps to chromosome 11p15.5, close to IGF2 and is expressed in extravillus trophoblasts.
Alders M; Hodges M; Hadjantonakis AK; Postmus J; van Wijk I; Bliek J; de Meulemeester M; Westerveld A; Guillemot F; Oudejans C; Little P; Mannens M
Hum Mol Genet; 1997 Jun; 6(6):859-67. PubMed ID: 9175731
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of ASCL1 and inhibition of Notch signaling pathway characterize progressive astrocytoma.
Somasundaram K; Reddy SP; Vinnakota K; Britto R; Subbarayan M; Nambiar S; Hebbar A; Samuel C; Shetty M; Sreepathi HK; Santosh V; Hegde AS; Hegde S; Kondaiah P; Rao MR
Oncogene; 2005 Oct; 24(47):7073-83. PubMed ID: 16103883
[TBL] [Abstract][Full Text] [Related]
14. miR-375 is highly expressed and possibly transactivated by achaete-scute complex homolog 1 in small-cell lung cancer cells.
Zhao H; Zhu L; Jin Y; Ji H; Yan X; Zhu X
Acta Biochim Biophys Sin (Shanghai); 2012 Feb; 44(2):177-82. PubMed ID: 22172490
[TBL] [Abstract][Full Text] [Related]
15. ASCL1 is a MYCN- and LMO1-dependent member of the adrenergic neuroblastoma core regulatory circuitry.
Wang L; Tan TK; Durbin AD; Zimmerman MW; Abraham BJ; Tan SH; Ngoc PCT; Weichert-Leahey N; Akahane K; Lawton LN; Rokita JL; Maris JM; Young RA; Look AT; Sanda T
Nat Commun; 2019 Dec; 10(1):5622. PubMed ID: 31819055
[TBL] [Abstract][Full Text] [Related]
16. Significance of achaete-scute complex homologue 1 (ASCL1) in pulmonary neuroendocrine carcinomas; RNA sequence analyses using small cell lung cancer cells and Ascl1-induced pulmonary neuroendocrine carcinoma cells.
Kudoh S; Tenjin Y; Kameyama H; Ichimura T; Yamada T; Matsuo A; Kudo N; Sato Y; Ito T
Histochem Cell Biol; 2020 Jun; 153(6):443-456. PubMed ID: 32170367
[TBL] [Abstract][Full Text] [Related]
17. POU domain transcription factor BRN2 is crucial for expression of ASCL1, ND1 and neuroendocrine marker molecules and cell growth in small cell lung cancer.
Ishii J; Sato H; Sakaeda M; Shishido-Hara Y; Hiramatsu C; Kamma H; Shimoyamada H; Fujiwara M; Endo T; Aoki I; Yazawa T
Pathol Int; 2013 Mar; 63(3):158-68. PubMed ID: 23530560
[TBL] [Abstract][Full Text] [Related]
18. Hypermethylation of adjacent CpG sites is negatively correlated with the expression of lineage oncogene ASCL1 in pulmonary neuroendocrine tumors.
Truong N; Chun SM; Kim TI; Suh YA; Jang SJ
Tumour Biol; 2017 Jun; 39(6):1010428317706225. PubMed ID: 28621224
[TBL] [Abstract][Full Text] [Related]
19. ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers.
Augustyn A; Borromeo M; Wang T; Fujimoto J; Shao C; Dospoy PD; Lee V; Tan C; Sullivan JP; Larsen JE; Girard L; Behrens C; Wistuba II; Xie Y; Cobb MH; Gazdar AF; Johnson JE; Minna JD
Proc Natl Acad Sci U S A; 2014 Oct; 111(41):14788-93. PubMed ID: 25267614
[TBL] [Abstract][Full Text] [Related]
20. Ascl1 phospho-status regulates neuronal differentiation in a Xenopus developmental model of neuroblastoma.
Wylie LA; Hardwick LJ; Papkovskaia TD; Thiele CJ; Philpott A
Dis Model Mech; 2015 May; 8(5):429-41. PubMed ID: 25786414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
